SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

2.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

3.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery

4.

Radiation therapy can promote amphiregulin, which increases growth of metastases

5.

AMA President-Elect Confronts a New Challenge: A Brain Tumor


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot